USPRegulatory IntelligenceStandardHIGH INSPECTION RISK
USP <1116>

Microbiological Control and Monitoring of Aseptic Processing Environments

Provides guidance on microbial environmental monitoring programs for aseptic manufacturing environments. Establishes principles for alert and action levels, program design, sampling methods, trending, and exceedance investigation.

LAST REVISED
May 2023
PRODUCT AREAS
Sterile
SCOPE & APPLICABILITY

Sterile product manufacturers using aseptic processing. The chapter is informational (not compendial) but is cited extensively by FDA and EMA inspectors.

KEY REQUIREMENTS
  • 01Defined sampling locations based on risk assessment with documented rationale
  • 02Alert and action levels scientifically established from historical data
  • 03Trending programme with defined review frequency and escalation triggers
  • 04Environmental isolate identification to genus/species for alert/action level exceedances
  • 05Investigation procedures for exceedances with root cause analysis requirements
  • 06Correlation of environmental results to product test results where applicable
IMPLEMENTATION TIPS
Statistical basis for alert/action levels should use historical data from the qualified state — document the calculation
Isolate library for your facility helps investigators identify recurrent contamination sources faster
Review EM data by location, by operator, and by time — trending needs all three dimensions
REVISION NOTES

Revised 2023. Key change: strengthened guidance on environmental isolate identification requirements.

USP <1116>: frequently asked questions

Quick answers to common questions about USP <1116>.

What is USP <1116>?

USP <1116> — Microbiological Control and Monitoring of Aseptic Processing Environments — is a standard issued by the United States Pharmacopeia (United States / International). Provides guidance on microbial environmental monitoring programs for aseptic manufacturing environments. Establishes principles for alert and action levels, program design, sampling methods, trending, and exceedance investigation.

Who does USP <1116> apply to?

Sterile product manufacturers using aseptic processing. The chapter is informational (not compendial) but is cited extensively by FDA and EMA inspectors.

What are the key requirements of USP <1116>?

USP <1116> requires, among other things: Defined sampling locations based on risk assessment with documented rationale; Alert and action levels scientifically established from historical data; Trending programme with defined review frequency and escalation triggers; Environmental isolate identification to genus/species for alert/action level exceedances.

When was USP <1116> last updated?

The current version of USP <1116> dates from May 2023. Revised 2023. Key change: strengthened guidance on environmental isolate identification requirements.

RELATED STANDARDS
SPEQ TEMPLATES FOR THIS STANDARD

Ready-to-use templates designed to help you comply with USP <1116>.

Browse 2 related templates
RELATED FDA RECALLS
where Environmental Monitoring control fails
See all Environmental Monitoring recalls →

Live openFDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.

THIS STANDARD IN PRACTICE

Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.

Weekly Briefing

Track the standards that move

When USP <1116> — or any GxP requirement — is revised, recalled against, or clarified by new guidance, the Weekly GxP Briefing surfaces it. Free, one email a week.

Read a past issue →